Aktis is a startup based in the United States, 4 tracked investors.
Aktis is a company founded in 2020 headquartered in the United States. Brouky records 4 investors associated with the company.
Aktis Oncology develops targeted alpha-based radiopharmaceuticals using a proprietary miniprotein radioconjugate platform to treat a broad range of solid tumor cancers with significant unmet medical needs.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.